期刊
CLINICA CHIMICA ACTA
卷 412, 期 21-22, 页码 1999-2001出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2011.06.028
关键词
Testosterone; ActivaTe Xtreme; Leuteinising hormone; LH; Supplement
资金
- Department of Health [DRF-2010-03-72] Funding Source: Medline
- National Institute for Health Research [DRF-2010-03-72] Funding Source: researchfish
- National Institutes of Health Research (NIHR) [DRF-2010-03-72] Funding Source: National Institutes of Health Research (NIHR)
A 19 year old male attended his GP with a history of fluid retention, lack of libido and erectile dysfunction. He was found to have a high serum testosterone, and a raised luteinising hormone. After further investigations, the patient admitted to taking a supplement called ActivaTe Xtreme (TM), obtained from an internet source, to address his low libido. ActivaTe Xtreme (TM) contains active ingredients which increase serum testosterone levels by several independent mechanisms that are not associated with luteinising hormone suppression. Urine analyses for synthetic anabolic steroids were negative, and urinary testosterone, epitestosterone and other androgens were normal. This biochemical pattern is not the same as that seen with anabolic steroids (i.e. raised testosterone, suppressed luteinising hormone and abnormal urine steroid profile). The issue of self medication with performance enhancing compounds needs to be carefully considered in order to avoid expensive and invasive investigations, missing an underlying pathology or misdiagnosing a patient. This case also raises the spectre of yet another performance enhancing product that may cause difficulty for those trying to ensure that sport remains on a hormonally equal basis. (C) 2011 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据